Story perspectives

Hims & Hers Shares Plummet Despite Record Revenue Growth

2/25/2025

48 4

Summary

Story summary

Hims & Hers Health shares dropped nearly 20% due to a gross margin decline to 77%, despite revenue nearly doubling to $481 million.
Earnings per share increased to 11 cents, exceeding analyst expectations.
The company projects first-quarter revenue between $520 million and $540 million, surpassing analyst consensus.
Recent FDA announcements have raised concerns regarding the company's weight-loss products.
Over the past year, Hims & Hers has experienced a remarkable 200% stock increase.

1 of 1

Story summary

Hims & Hers Health shares dropped nearly 20% due to a gross margin decline to 77%, despite revenue nearly doubling to $481 million.
Earnings per share increased to 11 cents, exceeding analyst expectations.
The company projects first-quarter revenue between $520 million and $540 million, surpassing analyst consensus.
Recent FDA announcements have raised concerns regarding the company's weight-loss products.
Over the past year, Hims & Hers has experienced a remarkable 200% stock increase.